ACPE UAN #: 0233-0000-16-069-H04-P
Release Date: October 6, 2016
Expiration Date: October 6, 2019
Activity Type: Knowledge-based
Contact Hours: 1.5
Activity Fee: Member: $15 Non-Member: $30
Target Audience: Pharmacists who practice in managed care settings.
Although specialty medications currently account for only 1% of all prescriptions, they consumed nearly 40% of the total drug spend in 2015 and could consume 50% by 2018. Specialty medications increasingly represent lifesaving breakthroughs or provide substantial therapeutic improvements, so payers are left scrambling to find ways to cover them. Now more than ever, payers need to anticipate high-cost, high-impact agents and proactively design innovative management strategies before new specialty medications reach the market.
This session is devoted to promising specialty medications that are expected to receive FDA approval within the next two years. Participants will leave armed with in-depth information about the efficacy, likely place in therapy, and probable budgetary impact of each of these medications—and ready to face the specter of spiraling drug costs.
At the completion of this activity, participants should be able to:
- Recognize high-impact specialty drugs in the 2017–2018 pharmaceutical pipeline.
- Summarize efficacy data for high-impact specialty pipeline drugs.
- Explain how emerging specialty pipeline drugs compare with currently available therapeutic options.
- Indicate the likely place in therapy and budgetary impact of emerging specialty pipeline drugs.
Schedule of Educational Activity
This activity consists of an audio recording, pre-test assessment questions (not required to pass or continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation.
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP Nexus 2016.
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites. View the minimum technical and system requirements for continuing education online learning activities.
As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.
Renee Rizzo Fleming, RPh, MBA
PRN Managed Care Consulting Services, LLC
East Amherst, New York
|Activity Number||Credit Amount||Accreditation Period|
|ACPE UAN #0233-0000-16-069-H04-P||1.5 Contact Hours||October 06, 2016 - October 06, 2019|